Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
---|
08/11/1999 | EP0934291A1 Protease inhibitors |
08/11/1999 | EP0934287A1 Heterocyclic esters and amides |
08/11/1999 | EP0934278A1 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents |
08/11/1999 | EP0934276A1 Anthranilic acid derivatives as multi drug resistance modulators |
08/11/1999 | EP0934252A1 Amide derivatives and their use as pesticides |
08/11/1999 | EP0934068A1 Compounds and methods |
08/10/1999 | US5935981 α-unsaturated amines, their production and use |
08/10/1999 | US5935978 Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group |
08/10/1999 | US5935966 Compounds that block the activation of transcription factors through inhibition of a family of specific kinases, decreasing proinflammatory proteins to treat autoimmune diseases and as general antiinflammatory agents |
08/10/1999 | US5935963 Piperazinones, their production and use |
08/10/1999 | US5935955 Substituted 3,6-dibenzylidene-2,5-piperazinediones, modulators of multidrug resistance |
08/05/1999 | WO1999038844A1 Method for preparing an n-[(aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
08/05/1999 | WO1999038829A1 Novel tricyclic compound |
08/05/1999 | DE19903870A1 New 3,3,5,5-tetraalkyl-2-oxo-1,4-piperazine derivatives, used as light, heat and oxygen stabilizers e.g. in photographic and reprographic materials and in paper |
08/05/1999 | CA2318601A1 Method for preparing an n-[(aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
08/04/1999 | EP0933354A1 Calcium receptor-active compounds |
08/04/1999 | EP0575490B1 GnRH ANALOGS |
08/04/1999 | CN1225083A Calcium receptor-active compounds |
08/04/1999 | CN1224717A Quinoxaline-1,4-dioxide derivative and its synthesis |
08/03/1999 | US5932731 Process for preparing aromatic or heteroaromatic sulfur compound |
08/03/1999 | US5932602 Treatment of platelet derived growth factor related disorders such as cancers |
08/03/1999 | US5932580 PDGF receptor kinase inhibitory compounds their preparation and compositions |
08/03/1999 | US5932579 Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use |
08/02/1999 | CA2260568A1 Oxopiperazinyl derivatives and light stabilized compositions |
07/29/1999 | WO1999037618A1 Phenylalanine derivatives useful as pharmaceutical agents |
07/29/1999 | WO1999037304A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS |
07/28/1999 | EP0931067A1 D4 receptor selectivity piperazine derivatives |
07/28/1999 | EP0611369B1 Process for preparing (s) (+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione) |
07/28/1999 | CN1044368C Pyrazine deriv. and its preparing method |
07/27/1999 | US5929077 Thioproline-containing inhibitors of farnesyl protein transferase |
07/27/1999 | US5929067 N-acylating amine derivative of caprolactam compound with a carboxylic acid or derivatives to form amide derivative of caprolactam compound |
07/27/1999 | CA2215327C Formulations for lipophilic compounds |
07/22/1999 | WO1999036393A1 INHIBITORS OF α4 MEDIATED CELL ADHESION |
07/21/1999 | EP0929528A1 Aralkyl and aralkylidene heterocyclic lactams and imides |
07/21/1999 | EP0929525A2 Novel heteroaryloxyethylamines, method of preparation, application as medicine and pharmaceutical compositions containing them |
07/21/1999 | EP0929217A1 Sordarin derivatives |
07/21/1999 | CN1223643A Prenyl transferase inhibitors |
07/21/1999 | CN1044242C Heterocyclic-cyclic amine derivatives |
07/20/1999 | USRE36256 Administering aryl-substituted quinoxaline derivatives as antiproliferative, anticarcinogenic and antitumor agents |
07/20/1999 | US5925641 Farnesyltransferase inhibitor |
07/14/1999 | CN1222909A Pyrazinone thrombin inhibitors |
07/14/1999 | CN1044117C Compound for inhibition of HIV protease, its preparing method and its drug use |
07/13/1999 | US5922873 Reacting a cyanopyrazine with tert-butyl alcohol in presence of sulfuric acid to prepare n-tert-butyl-2-pyrazinecarboxamide, hydrogenating the intermediate in presence of raney cobalt or raney nickel |
07/13/1999 | US5922870 Reacting pyridine-, pyrimidine-, pyrazine-, or 1,3,5-triazine halides with carbon monoxide and a primary or secondary amine in the presence of a complex of palladium with a diphosphine; chemical intermediates to herbicide synthesis |
07/13/1999 | US5922770 Novel compounds that stimulate the release of growth hormone from the pituitary |
07/13/1999 | US5922716 Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (ampa) receptor antagonists, non-competitive n-methyl-d-aspartate (nmda) receptor antagonists |
07/13/1999 | US5922715 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones |
07/13/1999 | US5922711 Antiallergens, antiinflammatory agents, autoimmune diseases, shock or analgesics |
07/13/1999 | US5922710 Iminooxybenzylcrotonate esters, their preparation and their use |
07/07/1999 | EP0927171A1 Pyrazinones and triazinones and their derivatives thereof |
07/07/1999 | EP0927170A1 Piperazino derivatives as neurokinin antagonists |
07/06/1999 | US5919930 Process for cross-coupling aromatic boron compounds with aromatic halogen compounds or perfluoroalkylsulfonates |
07/06/1999 | US5919777 Compounds with growth hormone releasing properties |
07/01/1999 | WO1999032478A1 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides |
07/01/1999 | WO1999032436A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
07/01/1999 | WO1999011621A3 Thiourea for increasing hdl-cholesterol levels, which are useful as anti-atherosclerotic agents |
06/30/1999 | EP0926216A1 Organic electroluminescent device using a triarylamine derivative |
06/30/1999 | EP0926138A1 Diamide compounds and drugs containing the same |
06/30/1999 | EP0926133A1 Iodide ion releasing compound, and silver halide light-sensitive photographic material containing the same |
06/30/1999 | EP0925287A1 Heterocyclic metalloprotease inhibitors |
06/30/1999 | CN1221422A Novel chiral bisphosphines |
06/30/1999 | CN1043887C Chemopreventive compound and preparation method and use thereof |
06/24/1999 | WO1999031065A1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia |
06/23/1999 | EP0923563A1 1,4-heterocyclic metallprotease inhibitors |
06/23/1999 | EP0923555A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
06/23/1999 | EP0923539A1 Compounds with growth hormone releasing properties |
06/23/1999 | CN1220664A Process for producing phenoxy propionic acid derivatives |
06/23/1999 | CN1220260A Acorus calamus extracts in Acorus gramineus and their use |
06/22/1999 | US5914344 Substituted carboxanilide derivative and plant disease control agent comprising same as active ingredient |
06/22/1999 | US5914332 Retroviral protease inhibiting compounds |
06/17/1999 | WO1999029700A2 Cyclohexadiene-derivatives as pesticides |
06/15/1999 | US5912387 Amine heat stable salt neutralization having reduced solids |
06/15/1999 | US5912245 Ampa and kainate antagonists. |
06/15/1999 | US5912243 Novel compounds for controlling nematodes, insect or acarid pests |
06/10/1999 | WO1999028359A1 Preparation for prevention and healing of inflammation affections |
06/10/1999 | WO1999028304A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions |
06/10/1999 | WO1999028299A1 1,2-dihydro-2-oxoquinoline derivatives |
06/10/1999 | CA2313055A1 1,2-dihydro-2-oxoquinoline derivatives |
06/10/1999 | CA2312749A1 Pdgf receptor kinase inhibitory compounds and compositions, method for synthesis of same and use of same for treatment of proliferate disorders |
06/09/1999 | EP0799207B1 Process for the preparation of fluorinated heterocyclic compounds |
06/09/1999 | CN1219170A Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
06/09/1999 | CN1218804A Organic second nonlinear optic response chromophore compound |
06/08/1999 | CA1340588C Amino acid derivatives |
06/03/1999 | WO1999026927A2 Metabotropic glutamate receptor antagonists for treating central nervous system diseases |
06/03/1999 | WO1999026921A1 SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS |
06/03/1999 | WO1999005096A3 Urokinase inhibitors |
06/03/1999 | CA2311131A1 Metabotropic glutamate receptor antagonists for treating central nervous system diseases |
06/03/1999 | CA2309341A1 Substituted .beta.-alanine derivatives as cell adhesion inhibitors |
06/02/1999 | CN1218045A Imide derivatives or salts thereof |
06/02/1999 | CN1218044A Urea derivatives |
06/01/1999 | US5908843 Thrombosis, antiinflammatory agent, arteriosclerosis, antitumor agents |
05/27/1999 | WO1999025702A1 Herbicidal n-alkenyl heteroarylyloxyacetamides |
05/27/1999 | WO1999025680A1 Crystals of [s,s]-ethylenediamine-n,n'-disuccinic acid with high bulk density and method of obtaining the same |
05/26/1999 | EP0752988B1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES ANTAGONISTS OF AMPA AND NMDA RECEPTORS |
05/26/1999 | EP0516795B1 Medicaments containing a quisqualate receptor antagonist and a dopamine agonist for the treatment of parkinson's disease |
05/26/1999 | CN1217725A Polymerisable composition |
05/25/1999 | US5906988 Methods of treatment using ranolazine and related piperazine derivatives |
05/20/1999 | WO1999024460A2 Dipeptide nitriles |
05/20/1999 | WO1999024403A1 N,n'-substituted carbamides used as a medicament |
05/19/1999 | EP0915855A1 Novel compounds with analgesic effect |